BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2003
View Archived Issues
BMS researchers describe two series of antidiabetic compounds
Read More
Novel immunosuppressants covered by Sankyo patent
Read More
Potent, selective PDE5 inhibitors prepared and tested at Lilly Icos
Read More
Agouron discovers novel nonpeptide GnRH antagonists
Read More
GSK scientists describe the discovery of novel anti-HCV agents
Read More
New antibacterial PDF inhibitors in early development at GSK
Read More
Pierre Fabre presents novel inhibitors of protein prenyltransferases
Read More
New data on cantuzumab mertansine in tumors expressing the CanAg antigen
Read More
Approval recommended for Enteryx in GERD
Read More
E.U. approves Taxotere in combination with cisplatin for first-line NSCLC treatment
Read More
CYC-202 enters phase IIa trials in breast and lung cancers
Read More
LidoPAIN IND cleared
Read More
ANDROMEDA trial discontinued due to safety concerns
Read More
Dosing begins in phase II trial of FM-VP4
Read More
Medarex and Abbott enter therapeutic antibody collaboration
Read More
Kiadis and U. of Bristol form neuropathic pain alliance
Read More
Applied Molecular Evolution completes preclinical validation of lead candidates
Read More
Potential use of nicotinic receptor antagonists as mood stabilizers in affective disorders
Read More
Hepacare marketing authorization withdrawn in E.U.
Read More
Disappointing phase II results reported for ReN-1869
Read More
HMR-1556 potently and selectively blocks the slowly activating delayed rectifier K+ current
Read More
Antimalarial activity of cyproheptadine involves inhibition of heme polymerization
Read More